Emerging therapeutic opportunities for integrin inhibitors

RJ Slack, SJF Macdonald, JA Roper… - Nature Reviews Drug …, 2022 - nature.com
Integrins are cell adhesion and signalling proteins crucial to a wide range of biological
functions. Effective marketed treatments have successfully targeted integrins αIIbβ3 …

High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review

TE Warkentin - Expert review of hematology, 2019 - Taylor & Francis
Introduction: Heparin-induced thrombocytopenia (HIT) is known for its strong association
with thrombosis and distinct pathogenesis involving anti-PF4/polyanion antibodies that …

Cryo-EM structures of full-length integrin αIIbβ3 in native lipids

BD Adair, JP Xiong, M Yeager, MA Arnaout - Nature Communications, 2023 - nature.com
Platelet integrin αIIbβ3 is maintained in a bent inactive state (low affinity to physiologic
ligand), but can rapidly switch to a ligand-competent (high-affinity) state in response to …

Pathophysiology and diagnosis of drug-induced immune thrombocytopenia

C Vayne, EA Guéry, J Rollin, T Baglo… - Journal of clinical …, 2020 - mdpi.com
Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …

Idiosyncratic adverse drug reactions: current concepts

J Uetrecht, DJ Naisbitt, Q Ma - Pharmacological reviews, 2013 - Elsevier
Idiosyncratic drug reactions are a significant cause of morbidity and mortality for patients;
they also markedly increase the uncertainty of drug development. The major targets are skin …

Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions

IJ Patel, JC Davidson, B Nikolic… - Journal of vascular …, 2012 - pubmed.ncbi.nlm.nih.gov
Consensus guidelines for periprocedural management of coagulation status and hemostasis
risk in percutaneous image-guided interventions Consensus guidelines for periprocedural …

Platelet bioreactor-on-a-chip

JN Thon, L Mazutis, S Wu, JL Sylman… - Blood, The Journal …, 2014 - ashpublications.org
Abstract Platelet transfusions total> 2.17 million apheresis-equivalent units per year in the
United States and are derived entirely from human donors, despite clinically significant …

Drug-induced thrombocytopenia: pathogenesis, evaluation, and management

JN George, RH Aster - ASH Education Program Book, 2009 - ashpublications.org
Although drugs are a common cause of acute immune-mediated thrombocytopenia in
adults, the drug etiology is often initially unrecognized. Most cases of drug-induced …

Approach to the diagnosis and management of drug-induced immune thrombocytopenia

DM Arnold, I Nazi, TE Warkentin, JW Smith… - Transfusion medicine …, 2013 - Elsevier
Drug-induced immune thrombocytopenia (DITP) is a challenging clinical problem that is
under-recognized, difficult to diagnose and associated with severe bleeding complications …

How do we approach thrombocytopenia in critically ill patients?

J Thachil, TE Warkentin - British journal of haematology, 2017 - Wiley Online Library
A low platelet count is a frequently encountered haematological abnormality in patients
treated in intensive treatment units (ITU s). Although severe thrombocytopenia (platelet …